Materials/Methods: Between 2008 and 2011, 53 patients with primary brain malignancies were treated with conventionally fractionated RT on a prospectively accrued clinical trial performed at our institution (WFU97100/91105). Tumor types included glioblastoma (13%), primitive neuroectodermal tumors (21%), and low grade/benign tumors (66%).Ten patients received whole brain RT with region boost, all other patients received partial brain RT. The median radiation dose was 54.0 Gy (range Z 40.0-60.6 Gy) delivered in 1.8 Gy/fraction (range Z 1.5-2.5 Gy/fraction). Dose-volume histogram analysis was performed for the hippocampus, parahippocampus, amygdala, and fusiform gyrus. Hopkins Verbal Learning Test-Revised (HVLT-R) scores were obtained at least 6 months after RT. Impairment was defined as a HVLT-R immediate recall score 15, based upon studies reporting optimal sensitivity and specificity for detecting impairment using HVLT-R cut-off scores of 14.5-15.5. For each anatomic region, serial regression was performed to correlate volume receiving a given dose (V D(Gy) ) with memory impairment. Results: Hippocampal V 53.4Gy -V 60.9Gy significantly predicted post-RT memory impairment (P < 0.05). Within this range, the hippocampal V 55Gy was the most significant predictor (P Z 0.004). Hippocampal V 55Gy of 0%, 25%, and 50% were associated with post-RT impairment rates of 14.9% (95% CI Z 7.2% -28.7%), 45.9% (95% CI Z 24.7% -68.6%), and 80.6% (95% CI Z 39.2% -96.4%), respectively. Dose received by the fusiform gyrus was a significant predictor of impairment, with the most significant relationship at V 46.5Gy (P Z 0.003). No statistically significant relationship was observed for the amygdala or parahippocampus. Conclusion: Injury to the hippocampus plays a fundamental role in CRCI. This analysis provides dosimetric guidelines to limit cognitive decline after cranial RT. The hippocampal V 55Gy is a significant predictor for impairment and limiting dose below 55 Gy may minimize treatment related neuro-cognitive toxicity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.